Clearpoint Neuro Correlations

CLPT Stock  USD 11.09  0.13  1.19%   
The current 90-days correlation between Clearpoint Neuro and Telesis Bio is -0.06 (i.e., Good diversification). The correlation of Clearpoint Neuro is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Clearpoint Neuro Correlation With Market

Weak diversification

The correlation between Clearpoint Neuro and DJI is 0.35 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Clearpoint Neuro and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clearpoint Neuro. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more information on how to buy Clearpoint Stock please use our How to Invest in Clearpoint Neuro guide.

Moving against Clearpoint Stock

  0.46DOCS DoximityPairCorr
  0.4FOXO FOXO TechnologiesPairCorr
  0.41CRVL CorVel Corp Normal TradingPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
NPCETMCI
SRDXINGN
TMCIRCEL
LUNGSGHT
APYXTMCI
SRDXTBIO
  
High negative correlations   
SGHTRCEL
TMCISGHT
INGNRCEL
NPCESGHT
RCELTBIO
OSASGHT

Risk-Adjusted Indicators

There is a big difference between Clearpoint Stock performing well and Clearpoint Neuro Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Clearpoint Neuro's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
TBIO  10.30  1.47  0.09 (0.85) 12.47 
 18.58 
 139.53 
RCEL  2.36  0.34  0.15  0.27  2.41 
 5.77 
 14.73 
SGHT  3.06 (1.05) 0.00 (0.22) 0.00 
 6.96 
 18.22 
TMCI  3.16 (0.01) 0.11  0.10  2.76 
 6.08 
 38.73 
NPCE  3.44  0.17  0.09  0.17  3.21 
 9.73 
 35.38 
INGN  1.92 (0.54) 0.00 (0.36) 0.00 
 2.66 
 22.50 
SRDX  0.48 (0.07) 0.00 (0.13) 0.00 
 1.26 
 3.22 
LUNG  3.25 (0.30) 0.00 (0.04) 0.00 
 9.00 
 20.52 
APYX  3.29  0.24  0.06  0.38  3.26 
 9.38 
 32.02 
OSA  104.70  50.88  1.97  3.14  13.81 
 51.22 
 168.97 

Clearpoint Neuro Corporate Management

Mazin SabraChief OfficerProfile
Danilo DAlessandroChief OfficerProfile
Ellisa JDGeneral SecretaryProfile
Ellisa CholapraneeGeneral SecretaryProfile
Jeremy StigallExecutive DeliveryProfile
Jacqueline KellerVice MarketingProfile